Clinical Trials Directory

Trials / Unknown

UnknownNCT05580822

Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion

Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion (ARTERIAL TNK BAO):a Prospective, Randomized, Open-label, Blinded Endpoint, Multicenter, Phase 2 Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
520 (estimated)
Sponsor
First Hospital of China Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Recent studies revealed the safety and effectiveness of EVT in patients with acute occlusion at basilar artery, showing that up to 46% of patients receiving EVT had favorable functional outcome at 3 months (ATTENTION and BAOCHE trials, ESOC). Although the rate of successful recanalization can be as high as 90% , a large number of these patients remains to be functionally independent while recovery. In addition, a number of recent studies indicated the functional outcome of patients with successful recanalization of TICI 2b was not as good as those with TICI 3 grade. Therefore, restoring reperfusion of distal vessels and territorial microcirculation may be pivotal to further improvement of neurological outcomes for AIS patients receiving EVT. Correspondingly, a very recent Spanish multicenter randomized trial showed the effect of further functional improvement of post-EVT intra-arterial alteplase for successful mechanical thrombectomy in anterior circulation More importantly, head-to-head comparison between TNK and tPA showed the former has a significantly higher chance of reperfusion, indicating that TNK may be a potentially better candidate for post-EVT bridging. Based on the above findings, we hypothesize in the present study that, adjunct intra-arterial tenecteplase after successful thrombectomy could enhance the functional improvement in patients with acute basilar artery occlusion.

Conditions

Interventions

TypeNameDescription
DRUGTenecteplase for Injectionintra-arterial TNK infusing after successful thrombectomy for patient with acute basilar artery occlusion via support/access catheter
DRUGSalineintra-arterial saline infusing after successful thrombectomy for patient with acute basilar artery occlusion via support/access catheter

Timeline

Start date
2023-01-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2022-10-14
Last updated
2022-10-14

Source: ClinicalTrials.gov record NCT05580822. Inclusion in this directory is not an endorsement.